Relonchem Limited have informed the MHRA that particles have been observed inside some bottles of Gabapentin Relonchem Oral Solution, identified through a customer complaint.
Important: This alert is gathered automatically for information only. Always refer to the original source and follow your practice’s own clinical governance procedures.
About this source
Alerts and Recalls for Drugs and Medical Devices - All